Evidence map›Paper›PMID 37254237›Full record

Trial reportOrthopaedic surgery2023

Feasibility Analysis of the Bone Cement-Gelatine Sponge Composite Intravertebral Prefilling Technique for Reducing Bone Cement Leakage in Stage I and II Kümmell's Disease: A Prospective Randomized Controlled Trial.

Chengqiang Zhou, Shaolong Huang, Yifeng Liao, Feng Zhang, Xiao Meng, Zhongjian Tang, Xu Zhang, Hua Li, Yao Zhang, Shuai Zhao and 1 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Orthopaedic surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Chengqiang ZhouGraduate School of Xuzhou Medical University, Xuzhou, China.ORCID https://orcid.org/0000-0001-6907-1163
Shaolong HuangGraduate School of Xuzhou Medical University, Xuzhou, China.
Yifeng LiaoGraduate School of Xuzhou Medical University, Xuzhou, China.
Feng ZhangGraduate School of Xuzhou Medical University, Xuzhou, China.
Xiao MengGraduate School of Xuzhou Medical University, Xuzhou, China.
Zhongjian TangGraduate School of Xuzhou Medical University, Xuzhou, China.
Xu ZhangGraduate School of Xuzhou Medical University, Xuzhou, China.
Hua LiDepartment of Orthopedics, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Yao ZhangDepartment of Orthopedics, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Shuai ZhaoDepartment of Orthopedics, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Yunqing WangDepartment of Orthopedics, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.ORCID https://orcid.org/0000-0002-7911-2608
Xuzhou Medical College · CN

Funding

Jiangsu Provincial Geriatric Health Research Project LK2021038Postgraduate Research & Practice Innovation Program of Jiangsu Province SJCX22_1287Xuzhou Special Fund for Promoting Scientific and Technological Innovation KC22204
6 · The paper itself

Abstract

objectiveBone cement leakage is a major complication of percutaneous vertebroplasty (PVP) while treating Kümmell's disease and it is a focus of close attention during the surgical procedure. The study aimed to investigate whether pre-injecting a composite of bone cement and gelatine sponge (the "bone cement-gelatine sponge composite") before injecting bone cement during PVP aids in lowering the leakage rate in stage I and II Kümmell's disease.

methodsThis prospective analysis evaluated 74 patients with stage I and II Kümmell's disease who underwent PVP treatment at our hospital from December 2019 to December 2021. The participants were divided randomly into groups based on whether the bone cement-gelatine sponge composite was used during the surgery. The two groups were the bone cement-gelatine sponge composite group (GS group, comprising 37 patients) and the no bone cement-gelatine sponge composite group (N-GS group, comprising 37 patients). The independent samples t-test and chi-square test were employed to compare general information, operative time, cement injection volume, intraoperative bleeding, and bone cement leakage between the two groups. Additionally, the visual analogue scale (VAS) score, Oswestry disability index (ODI), anterior vertebral height ratio (AVHR), and the kyphotic Cobb angle were compared between the two groups at the preoperative, 2 days postoperative, and 6 months postoperative stages using repeated measures analysis of variance.

resultsAll patients were followed up for more than 6 months, with an average of (11.19 ± 2.21) months. No significant differences were observed in terms of the operative time, cement injection volume, and intraoperative bleeding between the two groups (P > 0.05). The incidence of bone cement leakage in the N-GS group (32.43%) was significantly higher than that in the GS group (5.41%), and the difference was statistically significant (P < 0.05). The VAS score and ODI of the two groups at postoperative 2 days and 6 months improved significantly (P < 0.05). The AVHR and kyphotic Cobb angle were corrected to a certain extent (P < 0.05); however, no significant difference was observed between the two groups (P > 0.05).

conclusionThe bone cement-gelatine sponge composite intravertebral prefilling technique can lower bone cement leakage in stage I and II Kümmell's disease and can also relieve pain and improve vertebral body height.

Indexed as

Fractures, CompressionKyphoplastyKyphosisOsteoporotic FracturesSpinal FracturesSpondylosisVertebroplastyBone CementsFeasibility StudiesHumansRetrospective StudiesTreatment OutcomeBone CementsBone cement leakageGelatine spongeKümmell's diseasevertebral fractureVertebroplasty

Identifiers

PMID37254237
PMCPMC10350386
OpenAlexW4378783060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.